Literature DB >> 11433300

The PX domains of p47phox and p40phox bind to lipid products of PI(3)K.

F Kanai1, H Liu, S J Field, H Akbary, T Matsuo, G E Brown, L C Cantley, M B Yaffe.   

Abstract

PX domains are found in a variety of proteins that associate with cell membranes, but their molecular function has remained obscure. We show here that the PX domains in p47phox and p40phox subunits of the phagocyte NADPH oxidase bind to phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P(2)) and phosphatidylinositol-3-phosphate (PtdIns(3)P), respectively. We also show that an Arg-to-Gln mutation in the PX domain of p47phox, which is found in patients with chronic granulomatous disease, eliminates phosphoinositide binding, as does the analogous mutation in the PX domain of p40phox. The PX domain of p40phox localizes specifically to PtdIns(3)P-enriched early endosomes, and this localization is disrupted by inhibition of phosphoinositide-3-OH kinase (PI(3)K) or by the Arg-to-Gln point mutation. These findings provide a molecular foundation to understand the role of PI(3)K in regulating neutrophil function and inflammation, and to identify PX domains as specific phosphoinositide-binding modules involved in signal transduction events in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11433300     DOI: 10.1038/35083070

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  216 in total

1.  Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes.

Authors:  Vladiana Crljen; Stefano Volinia; Hrvoje Banfic
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 2.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

3.  Cooperative binding of the cytoplasm to vacuole targeting pathway proteins, Cvt13 and Cvt20, to phosphatidylinositol 3-phosphate at the pre-autophagosomal structure is required for selective autophagy.

Authors:  Daniel C Nice; Trey K Sato; Per E Stromhaug; Scott D Emr; Daniel J Klionsky
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

Review 4.  Phagosome maturation: aging gracefully.

Authors:  Otilia V Vieira; Roberto J Botelho; Sergio Grinstein
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

5.  The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly.

Authors:  Frederik Vilhardt; Bo van Deurs
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

6.  Phosphatidylinositol 4-kinasebeta is critical for functional association of rab11 with the Golgi complex.

Authors:  Petra de Graaf; Wilbert T Zwart; Remco A J van Dijken; Magdalena Deneka; Thomas K F Schulz; Niels Geijsen; Paul J Coffer; Bart M Gadella; Arie J Verkleij; Peter van der Sluijs; Paul M P van Bergen en Henegouwen
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

Review 7.  Phagosome maturation: a few bugs in the system.

Authors:  C C Scott; R J Botelho; S Grinstein
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

8.  Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria.

Authors:  Otilia V Vieira; Rene E Harrison; Cameron C Scott; Harald Stenmark; David Alexander; Jun Liu; Jean Gruenberg; Alan D Schreiber; Sergio Grinstein
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 9.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

10.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.